Cell Reports (Jan 2020)

Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis

  • Yeonsoo Joe,
  • Yingqing Chen,
  • Jeongmin Park,
  • Hyo Jeong Kim,
  • So-Young Rah,
  • Jinhyun Ryu,
  • Gyeong Jae Cho,
  • Hye-Seon Choi,
  • Stefan W. Ryter,
  • Jeong Woo Park,
  • Uh-Hyun Kim,
  • Hun Taeg Chung

Journal volume & issue
Vol. 30, no. 4
pp. 1063 – 1076.e5

Abstract

Read online

Summary: The resolution phase of acute inflammation is essential for tissue homeostasis, yet the underlying mechanisms remain unclear. We demonstrate that resolution of inflammation involves interactions between CD38 and tristetraprolin (TTP). During the onset of acute inflammation, CD38 levels are increased, leading to the production of Ca2+-signaling messengers, nicotinic acid adenine dinucleotide phosphate (NAADP), ADP ribose (ADPR), and cyclic ADPR (cADPR) from NAD(P)+. To initiate the onset of resolution, TTP expression is increased by the second messengers, NAADP and cADPR, which downregulate CD38 expression. The activation of TTP by Sirt1-dependent deacetylation, in response to increased NAD+ levels, suppresses the acute inflammatory response and decreases Rheb expression, inhibits mTORC1, and induces autophagolysosomes for bacterial clearance. TTP may represent a mechanistic target of anti-inflammatory agents, such as carbon monoxide. TTP mediates crosstalk between acute inflammation and autophagic clearance of bacteria from damaged tissue in the resolution of inflammation during sepsis. : Sepsis as a clinical syndrome is characterized by systemic inflammation and widespread tissue injury. Joe et al. suggest that the activation of TTP, an RNA binding protein, helps to ameliorate the inflammatory response and promote bacterial clearance in sepsis. Keywords: acute inflammation, autophagolysosome, CD38, Rheb, resolution of inflammation, sepsis, Sirt1, tristetraprolin